Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-10-25-Speech-2-073-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-10-25"^^xsd:date2
dcterms:Is Part Of	lp_eu:Question Time (Commission)2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20111025.7.2-073-000"2
lpv:hasSubsequent	lp_eu:2011-10-25-Speech-2-074-0002
lpv:speaker	lp:Dagmar Roth-behrendt2
lpv:spokenAs	member; ENVI (2009-07-16--2012-01-18)3 member; Parliament's Bureau (2009-07-14--2012-01-16)3 member; Delegation to the EU-Chile Joint Parliamentary Committee (2009-09-16--2014-06-30)3 substitute; JURI (2009-07-16--2012-01-18)3 substitute; Delegation for relations with the United States (2009-09-16--2014-06-30)3 vice-president; European Parliament (2009-07-14--2012-01-16)3 unknown; Sozialdemokratische Partei Deutschlands (2009-07-14--2014-06-30)3 member; S&D (2009-07-14--2014-06-30)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3
lpv:translated text	"Madam President, Commissioner, medicinal products are one of the most important things that help people to get healthy, but, at the same time, they pose an enormous risk. Do you agree with me that our approach needs to be more harmonised? Do you agree with me that the ‘notified bodies’ in the Member States do not work well? Do you agree with me that the new legislation that you are going to bring forward over the next year must therefore ensure, on behalf of patients, that there is a body that checks in a uniform and harmonised way whether a medicinal product really is safe for patients? Do you further agree with me that it is necessary, for the wellbeing of patients in the European Union, for us to clearly define the use of any given product – whether on a one-off or repeated basis – and not to leave this in the hands of the industry."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph